Candel Therapeutics Grants Options on 107,600 Shares to Four New Employees

• Candel Therapeutics granted four new employees stock options to purchase 107,600 shares on Oct. 31, 2026.
• The options carry an exercise price of $8.33 per share under the 2025 Inducement Plan.
• Vesting covers 25% of the underlying shares on the first anniversary of each employee’s start date.
• The remaining 75% vests in 36 equal monthly installments thereafter. All vesting requires continued service through the applicable vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021605PRIMZONEFULLFEED9868140) on November 02, 2026, and is solely responsible for the information contained therein.